{"data": [{"news_url": "https://www.investors.com/news/technology/mrna-stock-moderna-inks-covid-19-vaccine-supply-pact-astrazeneca-posts-positive-data/", "image_url": "https://cdn.snapi.dev/images/v1/e/r/syringe-3902915-1920-11.jpg", "title": "Covid Roundup: AstraZeneca Reports Positive Covid-19 Vaccine Data; Moderna Inks New Supply Deal", "text": "AstraZeneca posted positive interim Phase 2 testing data on its Covid-19 vaccine candidate in older adults, while Moderna inked a supply contract with Qatar, as MRNA stock, AZN stock rose. The post Covid Roundup: AstraZeneca Reports Positive Covid-19 Vaccine Data; Moderna Inks New Supply Deal appeared first on Investor's Business Daily.", "source_name": "Investors Business Daily", "date": "Mon, 26 Oct 2020 09:26:28 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["AZN", "MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/10/26/whats-the-best-way-to-invest-in-coronavirus-vaccin/", "image_url": "https://cdn.snapi.dev/images/v1/p/o/podc9---ajlptxtusp.jpg", "title": "What's the Best Way to Invest in Coronavirus Vaccine Stocks?", "text": "Here are three potential strategies.", "source_name": "The Motley Fool", "date": "Mon, 26 Oct 2020 08:14:00 -0400", "topics": ["podcast"], "sentiment": "Neutral", "type": "Article", "tickers": ["AZN", "BNTX", "JNJ", "MRNA", "NVAX", "PFE"]}, {"news_url": "https://www.businesswire.com/news/home/20201026005485/en/Moderna-Announces-Supply-Agreement-with-the-Ministry-of-Public-Health-to-Supply-Qatar-with-mRNA-Vaccine-Against-COVID-19-mRNA-1273/", "image_url": "https://cdn.snapi.dev/images/v1/p/r/press12---jeitfpj5ed.jpg", "title": "Moderna Announces Supply Agreement with the Ministry of Public Health to Supply Qatar with mRNA Vaccine Against COVID-19 (mRNA-1273)", "text": "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna announces supply agreement with the Ministry of Public Health to supply Qatar with mRNA vaccine against COVID-19 (mRNA-1273)", "source_name": "Business Wire", "date": "Mon, 26 Oct 2020 07:00:00 -0400", "topics": ["PressRelease"], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/10/26/are-coronavirus-vaccine-stocks-too-expensive/", "image_url": "https://cdn.snapi.dev/images/v1/v/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5916012fhypodermic-needles-syringe-drug-pharmajpgw700opresize.jpg", "title": "Are Coronavirus Vaccine Stocks Too Expensive?", "text": "It's important to look at the big picture.", "source_name": "The Motley Fool", "date": "Mon, 26 Oct 2020 06:10:00 -0400", "topics": ["podcast"], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA", "NVAX", "PFE"]}]}